Paul B Rosenberg MD
Geriatric Psychiatry
Associate Professor of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine; Associate Director, Memory and Alzheimer''s Treatment Center Division of Geriatric Psychiatry and Neuropsychiatry
Join to View Full Profile
5300 Alpha Commons DriveFloor 4Baltimore, MD 21224
Phone+1 410-550-6337
Fax+1 410-550-5992
Dr. Rosenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paul Rosenberg is a psychiatrist in Baltimore, MD and is affiliated with Johns Hopkins Bayview Medical Center. He received his medical degree from University of Maryland School of Medicine and has been in practice 32 years. He specializes in geriatric psychiatry and is experienced in depression, delirium, and dementa. He has > 130 peer-reviewed publications. He is currently recruiting for trials of escitalopram and THC for agitation in Alzheimer's, psilocybin for depression in mild cognitive impairment, and trazodone for sleep and cognition in mild cognitive impairment.
Education & Training
Mass General Brigham/Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1990 - 1991
Tufts Medical CenterResidency, Psychiatry, 1988 - 1990
Boston University Medical CenterInternship, Internal Medicine, 1985 - 1986
University of Maryland School of MedicineClass of 1985
Harvard UniversityBA, Magna Cum Laude, 1979
Certifications & Licensure
MD State Medical License 1991 - 2027
MA State Medical License 1986 - 2005
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
Clinical Trials
- Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease Start of enrollment: 2017 Mar 01
- Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI) Start of enrollment: 2021 May 21
- Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone Start of enrollment: 2023 Feb 02
Roles: Contact
Publications & Presentations
PubMed
- Impact of long-term systolic blood pressure on cognitive disorder risk: Across different age groups and antihypertensive medication timing.Konstantina Skolariki, Paul B Rosenberg, Sevil Yasar, Esther S Oh, Jeannie Leoutsakos
Journal of Alzheimer's Disease. 2026-02-01 - 1 citationsA Randomized Controlled Trial of the Safety and Efficacy of Dronabinol for Agitation in Alzheimer's Disease.Paul B Rosenberg, Halima Amjad, Haroon Burhanullah, Milap Nowrangi, Ryan Vandrey
The American Journal of Geriatric Psychiatry. 2026-02-01 - Blood biomarkers for Alzheimer's disease are correlated with measures of agitation and cognition in a randomized trial assessing the effects of escitalopram on agitation.Maansi Barnwal, Sheriza Baksh, Zahinoor Ismail, David M Shade, Abhay Moghekar
Alzheimer's & Dementia. 2026-01-18
Journal Articles
- Effect of Depth of Sedation in Older Patients Undergoing Hip Fracture Repair on Postoperative DeliriumThe STRIDE Randomized Clinical TrialFrederick E Sieber, Allan Gottschalk, Karin J Neufeld, Simon C Mears, Erik A Hasenboehler, Esther S Oh, Mahmood Jaberi, George E Bigelow, Paul B Rosenberg, JAMA
- Neuropsychiatric Symptoms in Alzheimer's Disease: What Might Be Associated Brain Circuits?Rosenberg PB, Nowrangi MA, Lyketsos CG, Molecular Aspects of Medicine, 1/1/2015
- Effect of Medications on Physical Function and Cognition in Nursing Home Residents with DementiaDutcher SK, Rattinger GB, Langenberg P, Chhabra PT, Liu X, Rosenberg PB, Leoutsakos JM, Simoni-Wastila L, Walker LD, Franey CS, Zuckerman IH, J Am Geriatr Soc, 1/13/2014
Books/Book Chapters
Lectures
- Primary and Secondary Prevention of Alzheimer's DiseaseBaltimore, MD - 1/27/2014
- Development of treatments for depression in Alzheimer's DiseaseBaltimore, MD - 1/8/2014
- Clinical Trial Challenges in the Study of Age-related Cognitive Disorders1/19/2013
Other
- Emerging Imaging and Therapeutics in Alzheimer's Disease: Early Detection and InterventionVideotaping for Future Webcast on Medscape Spotlight, Sponsored by Vindico Medical Education
Boston MA - 1/14/2013 - Clinical Conversations in Alzheimer's DiseaseJHU CME for Webcast
1/2/2013 - Clinical Conversations in Alzheimer's Disease: Exploring the Diagnostic and Therapeutic FrontierWebinar CME
1/1/2013
Press Mentions
Dronabinol Safe, Effective for Alzheimer Disease with AgitationOctober 10th, 2024- Cannabis Product May Help Ease Agitation of Alzheimer’sOctober 9th, 2024
- Clinical Trial Shows Synthetic Cannabis Reduces Agitation in Alzheimer’s DiseaseOctober 2nd, 2024
Grant Support
- Diads-3: An RCT Of Venlafaxine For Depression In ADNational Institute On Aging2011
- The Role Of STIM1 In Cardiac And Skeletal Muscle FunctionNational Heart, Lung, And Blood Institute2009–2011
- PET Imaging Of Activated Microglia In Alzheimer'S DiseaseNational Institute On Aging2008–2011
- Apathy In Alzheimer'S Disease Methylphenidate TrialNational Institute On Aging2009–2010
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/paul-rosenberg
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
